Latest Technology Platforms News

Woolworths Group reported a 3.6% normalised sales increase to $69.1 billion for FY25, yet earnings before interest and tax fell 12.6%, weighed down by Australian Food and BIG W segments. The group plans a turnaround in FY26 amid ongoing cost pressures and strategic shifts.

EML Payments Limited reported a 9% revenue increase and 13% rise in underlying EBITDA for FY25, while advancing its EML2.0 transformation and Project Arlo technology platform. Despite a net loss impacted by a shareholder class action provision, the company’s renewed client pipeline and strategic restructuring signal a pivotal phase ahead.

Lovisa Holdings has reported a robust FY25 with revenue climbing 14.2% and over 160 new stores opened worldwide, signaling strong momentum in the fashion jewellery sector.

Atturra Limited reported a robust 24% increase in revenue and underlying EBITDA for FY25, driven by six strategic acquisitions and expanded government contracts. Despite a slight dip in net profit, the company is poised for further growth with a 10% share buyback and a strong focus on AI and enterprise solutions.

Calix Limited reported a 17% rise in product and services revenue for FY25, driven by its Magnesia and Leilac businesses, alongside a 23% reduction in operating expenses. The company extended its cash runway to 18 months, supported by a $21 million equity raise, while progressing key decarbonisation projects.

Calix Limited reported solid FY25 results with 17% growth in product revenue, a 23% cut in operating costs, and an extended 18-month cash runway, while progressing key decarbonisation projects.

Calix Limited reported a $20.1 million loss for FY2025 despite an 11.2% increase in revenue, reflecting ongoing investment in its industrial decarbonisation technology platform.

Helloworld Travel Limited reported a 4.1% rise in profit after tax for FY25 despite an 8.6% decline in total transaction value, underpinned by strong forward bookings and ongoing technology investments.

Beforepay Group Limited reported a robust 74.5% increase in net profit after tax to $6.7 million for FY25, driven by growth in its core Pay Advance business, the launch of a Personal Loan product, and expansion of its AI-powered credit analytics division, Carrington Labs, in the US.

Noxopharm has successfully completed the third dosing phase of its HERACLES trial for SOF-SKN™, confirming safety and moving forward to the highest dose cohort in this pioneering autoimmune drug study.

Vitura Health reported modest revenue growth but a robust 23.5% increase in EBITDA for FY2025, fueled by key acquisitions and expanding telehealth services. Despite margin pressures in medicinal cannabis, the company’s strategic reset under new leadership sets the stage for further growth.

Vitura Health reported a modest revenue increase to $124 million for FY2025, while net profit dipped 5.35% due to margin pressures and investment in new platforms. The company declared a fully franked dividend and highlighted growth in telehealth and medical services.